Cost-effectiveness analysis of individual-level obesity treatment in paediatrics: A scoping review

Ashwin Dhillon1, Madeline Mayer1, Lynn Kysh2

  • 1Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA.

Pediatric Obesity
|January 30, 2024
PubMed

Insights

This review found that individual paediatric obesity treatments, particularly behavioural interventions, are cost-effective. Future research should address methodological challenges in economic evaluations for better decision-making.

Area of Science:

  • Health Economics
  • Paediatric Obesity Treatment
  • Intervention Cost-Effectiveness

Background:

  • Paediatric obesity is a growing public health concern requiring effective and economically viable treatment strategies.
  • Health economics provides a framework for evaluating the value of healthcare interventions, including those for childhood obesity.
  • Understanding the cost-effectiveness of different paediatric obesity treatments is crucial for resource allocation and clinical decision-making.

Purpose of the Study:

  • To conduct a scoping review on the health economics of paediatric obesity treatments.
  • To identify recently published research on the cost-effectiveness of interventions for paediatric obesity.
  • To determine the key characteristics of cost-effective paediatric obesity interventions.

Main Methods:

  • A systematic search of six databases (Medline, Embase, Cochrane CENTRAL, CINAHL, PsycINFO) was conducted up to March 2023.
  • Included studies focused on individual-level, weight management interventions (behavioural, pharmacotherapy, surgical) for youth aged 2-21 years with obesity.
  • Studies involving cost analysis were eligible for inclusion.

Main Results:

  • Out of 4371 records, 39 studies met the inclusion criteria, predominantly from high-income countries and published after 2010.
  • Thirty-five studies (90%) assessed lifestyle interventions, with 30 (85%) found to be cost-effective.
  • Four studies (10%) assessed surgical interventions, all of which were reported as cost-effective. No pharmacotherapy studies met the criteria.

Conclusions:

  • Individual-level paediatric obesity treatments, especially behavioural interventions, demonstrate cost-effectiveness and potential cost-savings.
  • Economic evaluations of paediatric obesity interventions face methodological challenges that require further research.
  • Addressing these challenges will enhance the utility of economic evaluations in guiding decision-making for paediatric obesity treatment.
Abstract